Stockhead on MSN21h
Health Check: Hearts are pumping as Anteris shares debut on the Nasdaq
Shares in heart valve innovator Anteris Technologies (ASX:AVR) are trading on the US Nasdaq exchange after the pricing of its ...
Hubbis7h
Rethinking Wealth: Prashant Joshi on 2024’s Transformative Trends and India’s Wealth Management Outlook
Reflecting on 2024, what were the most significant trends or challenges impacting your firm and India’s wealth management ...
Ever-Growing USA on MSN5d
Trump’s Return to the White House Ushers in a New Era: Elon Musk’s Starlink IPO Positioned for Takeoff
Starlink's "Backdoor Opportunity" Offers Investors a Rare Chance to Get Ahead of the Biggest IPO in History Washington, D.C, December 11, 2024 (Zeest Media) — As Donald Trump returns to the White ...
Benzinga.com24d
LIGHTON announces highly successful IPO on Euronext Growth Paris.
with the development of new Paradigm functionalities (development of agents, multimodal RAG capacities, etc.), the fine-tuning of specialised models for priority sectors and geographies ...
The Daily Telegraph20d
Health Check: Biotech double-banger breaks the IPO drought
Two new biotech companies – Vitrafy and Renerve – listed today, breaking an eight-month drought of life sciences IPOs on the ASX ... rose 0.8% to 65.5 cents. Paradigm Biopharmaceuticals ...
money.rediff4d
RMZ, CPPIB Invest USD 750 mn in Mumbai Commercial Project
RMZ Group and CPPIB are investing USD 750 million to develop a commercial project in Mumbai, 'RMZ Nexus', spanning 3.74 ...